Skip to main content
AirSculpt Q3 revenue falls 8.7% to $31.9 million
Image for illustrative purposes only. Not a real photo.

AirSculpt Q3 revenue falls 8.7% to $31.9 million

Share

Key points

  • AirSculpt Technologies (NASDAQ:AIRS) reported third-quarter 2026 revenue of $31.9 million, down 8.7% year over year, as procedure volumes declined.
  • Net loss narrowed to $7.173 million from $9.512 million, but adjusted EBITDA fell to $393,000 from $3.039 million.
  • AirSculpt reduced its 2026 revenue forecast to $144 million–$146 million and adjusted EBITDA guidance to $9 million–$10 million, while completing a $39 million debt refinancing.

AirSculpt Technologies (NASDAQ:AIRS) reported third-quarter 2026 revenue of $31.9 million, down 8.7% year over year, and lowered its full-year financial outlook following weaker demand for its body contouring procedures.

Revenue declined as same-center procedure volumes fell 9.6%, while nine-month revenue decreased 3.5% to $114.2 million, reflecting continued pressure on patient demand.

The company's net loss narrowed to $7.173 million from $9.512 million in the prior-year quarter, although adjusted EBITDA, a non-GAAP earnings measure, dropped to $393,000 from $3.039 million.

AirSculpt now expects full-year 2026 revenue of approximately $144 million–$146 million and adjusted EBITDA of $9 million–$10 million, below its previous forecasts, while September-end cash stood at $15.182 million and quarterly operating cash outflow reached $3.475 million.

On November 5, AirSculpt completed a refinancing that provided a $39 million funded senior secured term loan and an undrawn revolving credit facility of up to $5 million, both maturing November 5, 2031.

AirSculpt provides minimally invasive body contouring procedures through its proprietary AirSculpt technology, operating specialised treatment centres across the United States and Canada.SEO and publishing metadata


Frequently asked questions